Serastrands Biotherapeutics Private Limited, a active private limited company, was established on 18 September 2019 in Bangalore, Karnataka, India. Engaging in biotechnology within the professional, scientific and technical sector, it holds CIN: U36994KA2019PTC128062. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Sujatha Shrinivas (Director), Natarajan Essakimuthu (Director). Past directors included Velmurugan Balasubramanian, Natarajan Essakimuthu. Its latest AGM occurred on 05 September 2024, with the balance sheet filed on 31 March 2024. It is based at #677, 13Th Cross, 1St Sector, Hsr L/O,, Bangalore, Karnataka, 560102.
U36994KA2019PTC128062
128062
18 September 2019
₹1.00 M
₹0.10 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Serastrands Biotherapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sujatha Shrinivas | Director | 18 Sep 2019 | Current |
| Natarajan Essakimuthu | Director | 29 Oct 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 29 Oct 2019 | Past |
| Pramod Abcsdd | Additional Director | 20 Mar 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Serastrands Biotherapeutics Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 92.29% decrease. The company also saw a substantial fall in profitability, with a 356.88% decrease in profit. The company's net worth observed a substantial decline by a decrease of 81.73%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Serastrands Biotherapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Serastrands Biotherapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Serastrands Biotherapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Serastrands Biotherapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Serastrands Biotherapeutics Private Limited last Annual general meeting of members was held on 05 Sep 2024 as per latest MCA records. was documented.
The activity Serastrands Biotherapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was completed.
Progress on Natarajan Essakimuthu was appointed as a Director was appointed as a Director on 29 Oct 2019 & has been associated with this company since 6 years 1 month . was documented.
The activity Sujatha Shrinivas was appointed as a Director was appointed as a Director on 18 Sep 2019 & has been associated with this company since 6 years 3 months . was completed.
Progress on Serastrands Biotherapeutics Private Limited was registered on 18 Sep 2019 with Roc Bangalore & aged 6 years 3 months as per MCA records. was documented.
The CIN of Serastrands Biotherapeutics Private Limited is U36994KA2019PTC128062.
Serastrands Biotherapeutics Private Limited is headquartered at #677, 13Th Cross, 1St Sector, Hsr L/O,, Bangalore, Karnataka, 560102.
Serastrands Biotherapeutics Private Limited was incorporated on 18 September 2019.
The current directors of Serastrands Biotherapeutics Private Limited are
The primary industry of Serastrands Biotherapeutics Private Limited is Professional, Scientific And Technical.
Serastrands Biotherapeutics Private Limited is unlisted.
The authorized capital of Serastrands Biotherapeutics Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX